These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

497 related articles for article (PubMed ID: 17574165)

  • 81. Drug-eluting stent implantation in bifurcated lesions with balloon-crushing technique and 6 fr guiding catheter: immediate and mid-term results.
    Lozano I; Avanzas P; Lee DH; Lasa G; Rondán J; Moris C
    J Invasive Cardiol; 2007 Jan; 19(1):27-31. PubMed ID: 17297182
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Drug-eluting stenting of unprotected left main coronary artery stenosis in patients with orthotopic heart transplantation: Initial clinical experience.
    Lee MS; Chun KJ; Tobis JM
    Catheter Cardiovasc Interv; 2008 Feb; 71(3):306-11. PubMed ID: 18288757
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Comparison of medical treatment and coronary revascularization in patients with moderate coronary lesions and borderline fractional flow reserve measurements.
    Courtis J; Rodés-Cabau J; Larose E; Déry JP; Nguyen CM; Proulx G; Gleeton O; Roy L; Barbeau G; Noël B; DeLarochellière R; Bertrand OF
    Catheter Cardiovasc Interv; 2008 Mar; 71(4):541-8. PubMed ID: 18307236
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Readmission rate after coronary artery bypass grafting versus percutaneous coronary intervention for unprotected left main coronary artery narrowing.
    Roh JH; Kim YH; Ahn JM; Yun SH; Lee JB; Ge J; Le W; Park GM; Lee JY; Park DW; Kang SJ; Lee SW; Lee CW; Park SW; Park SJ
    Am J Cardiol; 2014 May; 113(10):1639-46. PubMed ID: 24666619
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Long-term clinical outcomes after intravascular brachytherapy for instent restenosis and de novo coronary artery lesions in percutaneous coronary intervention.
    Ho HH; Kwok OH; Jim MH; Siu CW; Pong V; Chow WH
    Cardiovasc Revasc Med; 2011; 12(3):152-157. PubMed ID: 21640933
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Differences between early, intermediate, and late angioplasty after coronary artery bypass grafting.
    Tan ES; Jessurun G; Deurholt W; van der Vleuten P; van den Heuvel A; Ebels T; Zijlstra F; Tio R
    Crit Pathw Cardiol; 2008 Dec; 7(4):239-44. PubMed ID: 19050420
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Results of percutaneous coronary intervention of the unprotected left main coronary artery in 143 patients and comparison of 30-day mortality to results of coronary artery bypass grafting.
    Dubois C; Dens J; Sinnaeve P; Belmans A; Van Cleemput J; Mendez M; Piessens J; Desmet W
    Am J Cardiol; 2008 Jan; 101(1):75-81. PubMed ID: 18157969
    [TBL] [Abstract][Full Text] [Related]  

  • 88. What can we expect in PCI in patients with chronic coronary artery disease. - Indication of PCI for angiographically significant coronary artery stenosis without objective evidence of myocardial ischemia (Con)-.
    Akasaka T
    Circ J; 2011; 75(1):211-7; discussion 210. PubMed ID: 21173503
    [TBL] [Abstract][Full Text] [Related]  

  • 89. EuroSCORE is a good global predictor of long-term outcomes in high-risk but not in low-risk patients after unprotected left main angioplasty.
    Rekik S; Brunet J; Bayet G; Hager FX; Meille L; Quatre JM; Sainsous J
    Catheter Cardiovasc Interv; 2011 Apr; 77(5):625-32. PubMed ID: 20578163
    [TBL] [Abstract][Full Text] [Related]  

  • 90. A preliminary experience report: Drug-eluting stents versus coronary artery bypass surgery in patients with a single lesion in the proximal left anterior descending artery suffering from diabetes mellitus and chronic stable angina.
    Toutouzas K; Patsa C; Vaina S; Tsiamis E; Vavuranakis M; Stefanadi E; Spanos A; Iliopoulos D; Panagiotou M; Chlorogiannis I; Pattakos E; Stefanadis C
    Hellenic J Cardiol; 2008; 49(2):65-71. PubMed ID: 18459462
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Percutaneous coronary intervention of unprotected left main coronary artery disease: procedural strategies and technical considerations.
    Lee MS; Stone GW; Park SJ; Teirstein P; Moses J; Colombo A; Kandzari DE
    Catheter Cardiovasc Interv; 2012 Apr; 79(5):812-22. PubMed ID: 21793172
    [TBL] [Abstract][Full Text] [Related]  

  • 92. High-risk diabetic patients with unprotected left main coronary artery disease: characteristics and medium-term outcomes of percutaneous revascularization with drug-eluting stents.
    Fernández JF; González CS; Navarro MJ; Fernández Guerrero JC; Menchero AG; Briales JH; Piris RM; Herrador J; Herrera MG; García JM
    Tex Heart Inst J; 2011; 38(4):386-91. PubMed ID: 21841866
    [TBL] [Abstract][Full Text] [Related]  

  • 93. A collaborative systematic review and meta-analysis on 1278 patients undergoing percutaneous drug-eluting stenting for unprotected left main coronary artery disease.
    Biondi-Zoccai GG; Lotrionte M; Moretti C; Meliga E; Agostoni P; Valgimigli M; Migliorini A; Antoniucci D; Carrié D; Sangiorgi G; Chieffo A; Colombo A; Price MJ; Teirstein PS; Christiansen EH; Abbate A; Testa L; Gunn JP; Burzotta F; Laudito A; Trevi GP; Sheiban I
    Am Heart J; 2008 Feb; 155(2):274-83. PubMed ID: 18215597
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Perioperative rupture of the LIMA graft leading to cardiogenic shock, emergency angiography, and stenting with a polytetrafluoroethylene-covered stent.
    Yeow WL; Edwards M; Yong G
    Catheter Cardiovasc Interv; 2012 Mar; 79(4):640-3. PubMed ID: 21542101
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Percutaneous coronary intervention with rotational atherectomy for severely calcified unprotected left main: immediate and two-years follow-up results.
    Garcia-Lara J; Pinar E; Valdesuso R; Lacunza J; Gimeno JR; Hurtado JA; Valdés-Chávarri M
    Catheter Cardiovasc Interv; 2012 Aug; 80(2):215-20. PubMed ID: 22121088
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Impact of renal insufficiency on clinical and angiographic outcomes following percutaneous coronary intervention with sirolimus-eluting stents.
    Nakazawa G; Tanabe K; Aoki J; Yamamoto H; Higashikuni Y; Onuma Y; Yachi S; Nakajima H; Hara K
    Catheter Cardiovasc Interv; 2007 May; 69(6):808-14. PubMed ID: 17191206
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Impact of atherosclerotic disease progression on mid-term clinical outcome in diabetic patients in the drug-eluting stent era.
    Tousek P; Pavei A; Oreglia J; Martin G; Sharif F; Fajadet J; Farah B
    EuroIntervention; 2009 Mar; 4(5):588-92. PubMed ID: 19378678
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Sirolimus-eluting stents for treatment of complex bypass graft disease: insights from the SECURE registry.
    Costa M; Angiolillo DJ; Teirstein P; Gilmore P; Leon M; Moses J; Yakubov S; Carter A; Fischell T; Zenni M; Bass T
    J Invasive Cardiol; 2005 Aug; 17(8):396-8. PubMed ID: 16079441
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Coronary artery bypass grafting after percutaneous coronary intervention.
    Shahabuddin S; Sami SA; Ansari JA; Perveen S; Furnaz S; Fatimi S; Sharif H
    J Coll Physicians Surg Pak; 2012 May; 22(5):340-1. PubMed ID: 22538047
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Should the left main be covered entirely with drug-eluting stents in percutaneous intervention.
    Lozano I; Avanzas P; Moris C
    J Invasive Cardiol; 2006 Nov; 18(11):E276-8. PubMed ID: 17090829
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.